Retatrutide led to significant improvements across various cardiovascular risk factors, including waist circumference, cholesterol, and blood pressure
Many people with a healthy BMI or mild overweight status are now asking whether GLP-1 therapy could benefit their metabolic goals, and whether it's safe and appropriate for their situation
The Ultimate L-Carnitine Product
Semaglutide and retatrutide both cause nausea, constipation, and potential pancreatitis risk
The recent explosion in irresponsible and misleading advertising about compounded GLP-1 (glucagon-like peptide-1) drugs, like the Hims & Hers Super Bowl commercial, puts patients safety at risk, and we cannot stay silent. Semaglutide belongs to a class of drugs called incretin mimetics, which imitate gut hormones aiding in blood sugar regulation
Always consult with a healthcare provider when considering its use for mitigating the effects of other compounds